HEADER IMMUNE SYSTEM 28-AUG-03 1QVO TITLE STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND TITLE 2 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR TITLE 3 RESIDUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAINS ALPHA 1,ALPHA 2 AND ALPHA 3; COMPND 5 SYNONYM: MHC CLASS I ANTIGEN A*11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B, E; COMPND 10 SYNONYM: HDCMA22P; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: NEGATIVE FACTOR; COMPND 14 CHAIN: C, F; COMPND 15 SYNONYM: F-PROTEIN, 27 KDA PROTEIN, 3'ORF; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A OR HLAA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 11 OTHER_DETAILS: FROM 1 MAJOR HISTOCOMPATIBILITY COMPLEX; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: B2M; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: XA90; SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PHN1; SOURCE 22 MOL_ID: 3; SOURCE 23 SYNTHETIC: YES; SOURCE 24 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 25 ORGANISM_TAXID: 11676; SOURCE 26 OTHER_DETAILS: THE PEPTIDE WAS OBTAINED THROUGH STANDARD SOLID-PHASE SOURCE 27 PEPTIDE SYNTHESIS. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN SOURCE 28 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1. KEYWDS IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR L.LI,J.M.MCNICHOLL,M.BOUVIER REVDAT 5 30-OCT-24 1QVO 1 REMARK REVDAT 4 19-FEB-20 1QVO 1 SOURCE REMARK SEQADV REVDAT 3 11-OCT-17 1QVO 1 REMARK REVDAT 2 24-FEB-09 1QVO 1 VERSN REVDAT 1 01-JUN-04 1QVO 0 JRNL AUTH L.LI,M.BOUVIER JRNL TITL STRUCTURES OF HLA-A*1101 COMPLEXED WITH IMMUNODOMINANT JRNL TITL 2 NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE JRNL TITL 3 PRESENCE OF A MIDDLE, SECONDARY ANCHOR RESIDUE. JRNL REF J.IMMUNOL. V. 172 6175 2004 JRNL REFN ISSN 0022-1767 JRNL PMID 15128805 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.LI,N.PROMADEJ,J.M.MCNICHOLL,M.BOUVIER REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC REMARK 1 TITL 2 STUDIES OF HLA-A*1101 COMPLEXED WITH AN HIV-1 DECAPEPTIDE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 1195 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444902007928 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.9 REMARK 3 NUMBER OF REFLECTIONS : 39698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1988 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.22 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 170 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6336 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 427 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.86200 REMARK 3 B22 (A**2) : -0.94300 REMARK 3 B33 (A**2) : -1.91900 REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : -0.51600 REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.339 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.153 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.088 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.45 REMARK 3 BSOL : 53.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QVO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020124. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS HI-STAR REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40704 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 49.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, AMMONIUM ACETATE, SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.25000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 14 74.06 -150.53 REMARK 500 ARG A 17 30.39 -87.39 REMARK 500 ASP A 29 -124.87 58.70 REMARK 500 ARG A 114 106.67 -170.05 REMARK 500 THR A 225 94.28 -59.09 REMARK 500 GLN A 226 -30.07 162.10 REMARK 500 LYS A 243 151.00 179.98 REMARK 500 TRP A 274 -176.81 -65.11 REMARK 500 HIS B 31 134.66 -172.01 REMARK 500 PRO B 32 -177.13 -65.37 REMARK 500 LYS B 48 67.50 60.41 REMARK 500 LEU B 54 120.72 -38.56 REMARK 500 TRP B 60 -2.81 73.88 REMARK 500 ASP B 98 42.96 -81.43 REMARK 500 ASP D 29 -121.17 64.51 REMARK 500 ARG D 114 110.07 -162.13 REMARK 500 HIS D 188 160.37 173.09 REMARK 500 PRO D 193 98.40 -67.85 REMARK 500 SER D 195 -152.85 -165.27 REMARK 500 LYS D 243 146.71 -177.24 REMARK 500 GLN D 255 -9.50 -59.79 REMARK 500 PRO E 32 -177.35 -63.83 REMARK 500 LEU E 54 124.55 -39.13 REMARK 500 TRP E 60 -0.85 73.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURE OF HLA-A*1101, AN ALLELE OF THE HLA-A3 SUPERTYPE,IN REMARK 900 COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 REVEAL THE REMARK 900 PRESENCE OF A MIDDLE ANCHOR RESIDUE DBREF 1QVO A 1 275 UNP P13746 1A11_HUMAN 25 299 DBREF 1QVO B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 1QVO C 1 10 UNP P04602 NEF_HV1Z6 78 87 DBREF 1QVO D 1 275 UNP P13746 1A11_HUMAN 25 299 DBREF 1QVO E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 1QVO F 1 10 UNP P04602 NEF_HV1Z6 78 87 SEQADV 1QVO MET B 0 UNP P61769 CLONING ARTIFACT SEQADV 1QVO MET E 0 UNP P61769 CLONING ARTIFACT SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE TYR THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLN GLU THR ARG SEQRES 6 A 275 ASN VAL LYS ALA GLN SER GLN THR ASP ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ASP GLY SEQRES 8 A 275 SER HIS THR ILE GLN ILE MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 PRO ASP GLY ARG PHE LEU ARG GLY TYR ARG GLN ASP ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN ILE THR SEQRES 12 A 275 LYS ARG LYS TRP GLU ALA ALA HIS ALA ALA GLU GLN GLN SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY ARG CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP PRO PRO LYS THR HIS MET THR HIS HIS PRO ILE SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 GLN VAL PRO LEU ARG PRO MET THR TYR LYS SEQRES 1 D 275 GLY SER HIS SER MET ARG TYR PHE TYR THR SER VAL SER SEQRES 2 D 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLN GLU THR ARG SEQRES 6 D 275 ASN VAL LYS ALA GLN SER GLN THR ASP ARG VAL ASP LEU SEQRES 7 D 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ASP GLY SEQRES 8 D 275 SER HIS THR ILE GLN ILE MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 275 PRO ASP GLY ARG PHE LEU ARG GLY TYR ARG GLN ASP ALA SEQRES 10 D 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 D 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN ILE THR SEQRES 12 D 275 LYS ARG LYS TRP GLU ALA ALA HIS ALA ALA GLU GLN GLN SEQRES 13 D 275 ARG ALA TYR LEU GLU GLY ARG CYS VAL GLU TRP LEU ARG SEQRES 14 D 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 275 ASP PRO PRO LYS THR HIS MET THR HIS HIS PRO ILE SER SEQRES 16 D 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 D 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 275 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 275 TRP GLU SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 10 GLN VAL PRO LEU ARG PRO MET THR TYR LYS FORMUL 7 HOH *427(H2 O) HELIX 1 1 ALA A 49 GLU A 55 5 7 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLU A 253 GLN A 255 5 3 HELIX 8 8 ALA D 49 GLU D 55 5 7 HELIX 9 9 GLY D 56 TYR D 85 1 30 HELIX 10 10 ASP D 137 HIS D 151 1 15 HELIX 11 11 HIS D 151 GLY D 162 1 12 HELIX 12 12 GLY D 162 GLY D 175 1 14 HELIX 13 13 GLY D 175 GLN D 180 1 6 HELIX 14 14 GLU D 253 GLN D 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N ALA A 24 O PHE A 36 SHEET 4 A 8 HIS A 3 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 O ILE A 97 N TYR A 9 SHEET 6 A 8 PHE A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O ILE A 124 N ASP A 116 SHEET 8 A 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 B 4 LYS A 186 PRO A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 B 4 THR A 228 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 ASP A 223 0 SHEET 2 D 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 D 4 LEU A 270 ARG A 273 -1 O LEU A 272 N CYS A 259 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 E 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 H 8 GLU D 46 PRO D 47 0 SHEET 2 H 8 THR D 31 ASP D 37 -1 N ARG D 35 O GLU D 46 SHEET 3 H 8 ARG D 21 VAL D 28 -1 N ALA D 24 O PHE D 36 SHEET 4 H 8 HIS D 3 VAL D 12 -1 N ARG D 6 O TYR D 27 SHEET 5 H 8 THR D 94 VAL D 103 -1 O VAL D 103 N HIS D 3 SHEET 6 H 8 PHE D 109 TYR D 118 -1 O GLN D 115 N MET D 98 SHEET 7 H 8 LYS D 121 LEU D 126 -1 O ILE D 124 N ASP D 116 SHEET 8 H 8 TRP D 133 ALA D 135 -1 O THR D 134 N ALA D 125 SHEET 1 I 4 LYS D 186 HIS D 192 0 SHEET 2 I 4 THR D 200 PHE D 208 -1 O TRP D 204 N HIS D 188 SHEET 3 I 4 PHE D 241 VAL D 248 -1 O ALA D 245 N CYS D 203 SHEET 4 I 4 THR D 228 LEU D 230 -1 N GLU D 229 O ALA D 246 SHEET 1 J 4 LYS D 186 HIS D 192 0 SHEET 2 J 4 THR D 200 PHE D 208 -1 O TRP D 204 N HIS D 188 SHEET 3 J 4 PHE D 241 VAL D 248 -1 O ALA D 245 N CYS D 203 SHEET 4 J 4 ARG D 234 PRO D 235 -1 N ARG D 234 O GLN D 242 SHEET 1 K 4 GLU D 222 ASP D 223 0 SHEET 2 K 4 THR D 214 ARG D 219 -1 N ARG D 219 O GLU D 222 SHEET 3 K 4 TYR D 257 GLN D 262 -1 O HIS D 260 N THR D 216 SHEET 4 K 4 LEU D 270 ARG D 273 -1 O LEU D 272 N CYS D 259 SHEET 1 L 4 LYS E 6 SER E 11 0 SHEET 2 L 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 L 4 PHE E 62 PHE E 70 -1 O LEU E 64 N VAL E 27 SHEET 4 L 4 GLU E 50 HIS E 51 -1 N GLU E 50 O TYR E 67 SHEET 1 M 4 LYS E 6 SER E 11 0 SHEET 2 M 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 M 4 PHE E 62 PHE E 70 -1 O LEU E 64 N VAL E 27 SHEET 4 M 4 SER E 55 PHE E 56 -1 N SER E 55 O TYR E 63 SHEET 1 N 4 GLU E 44 ARG E 45 0 SHEET 2 N 4 GLU E 36 LYS E 41 -1 N LYS E 41 O GLU E 44 SHEET 3 N 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 N 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.03 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.03 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.04 CISPEP 1 TYR A 209 PRO A 210 0 0.30 CISPEP 2 HIS B 31 PRO B 32 0 -0.09 CISPEP 3 TYR D 209 PRO D 210 0 -0.05 CISPEP 4 HIS E 31 PRO E 32 0 -0.07 CRYST1 76.200 88.500 64.800 90.00 90.13 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013123 0.000000 0.000030 0.00000 SCALE2 0.000000 0.011299 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015432 0.00000